356 related articles for article (PubMed ID: 28754450)
1. Pathogenesis of biliary fibrosis.
Pinzani M; Luong TV
Biochim Biophys Acta Mol Basis Dis; 2018 Apr; 1864(4 Pt B):1279-1283. PubMed ID: 28754450
[TBL] [Abstract][Full Text] [Related]
2. Cholangiocytes in the pathogenesis of primary sclerosing cholangitis and development of cholangiocarcinoma.
Chung BK; Karlsen TH; Folseraas T
Biochim Biophys Acta Mol Basis Dis; 2018 Apr; 1864(4 Pt B):1390-1400. PubMed ID: 28844951
[TBL] [Abstract][Full Text] [Related]
3. Bile duct epithelia as target cells in primary biliary cirrhosis and primary sclerosing cholangitis.
Dienes HP; Lohse AW; Gerken G; Schirmacher P; Gallati H; Löhr HF; Meyer zum Büschenfelde KH
Virchows Arch; 1997 Aug; 431(2):119-24. PubMed ID: 9293893
[TBL] [Abstract][Full Text] [Related]
4. Primary Biliary Cholangitis: Its Pathological Characteristics and Immunopathological Mechanisms.
Tsuneyama K; Baba H; Morimoto Y; Tsunematsu T; Ogawa H
J Med Invest; 2017; 64(1.2):7-13. PubMed ID: 28373632
[TBL] [Abstract][Full Text] [Related]
5. The immunophysiology and apoptosis of biliary epithelial cells: primary biliary cirrhosis and primary sclerosing cholangitis.
Kawata K; Kobayashi Y; Gershwin ME; Bowlus CL
Clin Rev Allergy Immunol; 2012 Dec; 43(3):230-41. PubMed ID: 22689287
[TBL] [Abstract][Full Text] [Related]
6. Comparative histologic features among liver biopsies with biliary-pattern injury and confirmed clinical diagnoses.
Yu S; Vidal B; Peric M; Rosenbaum MW; Cates JMM; Gonzalez RS
Hum Pathol; 2024 Apr; 146():8-14. PubMed ID: 38479481
[TBL] [Abstract][Full Text] [Related]
7. Infiltration of inflammatory cells expressing mitochondrial proteins around bile ducts and in biliary epithelial layer may be involved in the pathogenesis in primary biliary cirrhosis.
Sasaki M; Kakuda Y; Miyakoshi M; Sato Y; Nakanuma Y
J Clin Pathol; 2014 Jun; 67(6):470-6. PubMed ID: 24407434
[TBL] [Abstract][Full Text] [Related]
8. Fibrotic Events in the Progression of Cholestatic Liver Disease.
Wu H; Chen C; Ziani S; Nelson LJ; Ávila MA; Nevzorova YA; Cubero FJ
Cells; 2021 May; 10(5):. PubMed ID: 34062960
[TBL] [Abstract][Full Text] [Related]
9. Manifestations of nonsuppurative cholangitis in chronic hepatobiliary diseases: morphologic spectrum, clinical correlations and terminology.
Ludwig J; Czaja AJ; Dickson ER; LaRusso NF; Wiesner RH
Liver; 1984 Apr; 4(2):105-16. PubMed ID: 6727581
[TBL] [Abstract][Full Text] [Related]
10. Keratin 7 expression in hepatic cholestatic diseases.
Sakellariou S; Michaelides C; Voulgaris T; Vlachogiannakos J; Manesis E; Tiniakos DG; Delladetsima I
Virchows Arch; 2021 Oct; 479(4):815-824. PubMed ID: 34312700
[TBL] [Abstract][Full Text] [Related]
11. T-lymphocyte subsets in liver tissues of patients with primary biliary cirrhosis (PBC), patients with primary sclerosing cholangitis (PSC), and normal controls.
Si L; Whiteside TL; Schade RR; Starzl TE; Van Thiel DH
J Clin Immunol; 1984 Jul; 4(4):262-72. PubMed ID: 6611346
[TBL] [Abstract][Full Text] [Related]
12. Chronic cholestatic liver diseases: clues from histopathology for pathogenesis.
Pollheimer MJ; Fickert P; Stieger B
Mol Aspects Med; 2014 Jun; 37():35-56. PubMed ID: 24141039
[TBL] [Abstract][Full Text] [Related]
13. The pathology of primary biliary cirrhosis and autoimmune cholangitis.
Ludwig J
Baillieres Best Pract Res Clin Gastroenterol; 2000 Aug; 14(4):601-13. PubMed ID: 10976017
[TBL] [Abstract][Full Text] [Related]
14. Lack of concomitant expression of ICAM-1 and HLA-DR on bile duct cells from patients with primary sclerosing cholangitis and primary biliary cirrhosis.
Broomé U; Hultcrantz R; Scheynius A
Scand J Gastroenterol; 1993 Feb; 28(2):126-30. PubMed ID: 8095102
[TBL] [Abstract][Full Text] [Related]
15. Apoptosis of biliary epithelial cells in primary biliary cirrhosis and primary sclerosing cholangitis.
Tinmouth J; Lee M; Wanless IR; Tsui FW; Inman R; Heathcote EJ
Liver; 2002 Jun; 22(3):228-34. PubMed ID: 12100573
[TBL] [Abstract][Full Text] [Related]
16. Cyr61 Alleviates Cholangitis by Inhibiting Cytotoxic Effects of CD8
Cheng TC; Li H; Luo X; Ju LL; Chen L; Shao JG; She YJ; Li M; Bian ZL
Curr Med Sci; 2021 Dec; 41(6):1205-1213. PubMed ID: 34787784
[TBL] [Abstract][Full Text] [Related]
17. Management of cholestatic disease in 2017.
de Vries E; Beuers U
Liver Int; 2017 Jan; 37 Suppl 1():123-129. PubMed ID: 28052628
[TBL] [Abstract][Full Text] [Related]
18. Frequent expression of MUC1 apomucin on biliary epithelial cells of damaged small bile ducts in primary biliary cirrhosis and chronic viral hepatitis: an immunohistochemical study.
Sasaki M; Nakanuma Y
Hepatology; 1996 Jun; 23(6):1313-7. PubMed ID: 8675144
[TBL] [Abstract][Full Text] [Related]
19. TGR5: pathogenetic role and/or therapeutic target in fibrosing cholangitis?
Keitel V; Reich M; Häussinger D
Clin Rev Allergy Immunol; 2015 Jun; 48(2-3):218-25. PubMed ID: 25138774
[TBL] [Abstract][Full Text] [Related]
20. [Cholestatic liver diseases].
Thimme R; Opitz OG; Blum HE; Kreisel W
Ther Umsch; 2004 Aug; 61(8):521-7. PubMed ID: 15457969
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
